-
1
-
-
43749089210
-
Anemia and chronic heart failure implications and treatment options
-
Anand IS. Anemia and chronic heart failure implications and treatment options. J Am Coll Cardiol 2008;52:501-511
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 501-511
-
-
Anand, I.S.1
-
2
-
-
0037458095
-
Anemia is common in heart failure and is associated with poor outcomes: Insights from a cohort of 12 065 patients with new-onset heart failure
-
Ezekowitz JA, McAlister FA, Armstrong PW. Anemia is common in heart failure and is associated with poor outcomes: insights from a cohort of 12 065 patients with new-onset heart failure. Circulation 2003;107:223-225
-
(2003)
Circulation
, vol.107
, pp. 223-225
-
-
Ezekowitz, J.A.1
McAlister, F.A.2
Armstrong, P.W.3
-
3
-
-
49849088979
-
Anemia and mortality in heart failure patients: A systematic review and metaanalysis
-
Groenveld HF, Januzzi J, Damman K, et al. Anemia and mortality in heart failure patients: a systematic review and metaanalysis. J Am Coll Cardiol 2008;52:818-827
-
(2008)
J Am Coll Cardiol
, vol.52
, pp. 818-827
-
-
Groenveld, H.F.1
Januzzi, J.2
Damman, K.3
-
4
-
-
14744278436
-
Anemia of chronic disease
-
Weiss G, Goodnough LT. Anemia of chronic disease. N Engl J Med 2005;352:1011-1023
-
(2005)
N Engl J Med
, vol.352
, pp. 1011-1023
-
-
Weiss, G.1
Goodnough, L.T.2
-
5
-
-
25444450031
-
Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure
-
DOI 10.1161/CIRCULATIONAHA.105.549121
-
Van der Meer P, Lipsic E, Westenbrink BD, et al. Levels of hematopoiesis inhibitor N-acetyl-seryl-aspartyl-lysyl-proline partially explain the occurrence of anemia in heart failure. Circulation 2005;112:1743-1747 (Pubitemid 41368150)
-
(2005)
Circulation
, vol.112
, Issue.12
, pp. 1743-1747
-
-
Van Der Meer, P.1
Lipsic, E.2
Westenbrink, B.D.3
Van De Wal, R.M.A.4
Schoemaker, R.G.5
Vellenga, E.6
Van Veldhuisen, D.J.7
Voors, A.A.8
Van Gilst, W.H.9
-
6
-
-
1642393242
-
Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women
-
Brownlie TT, Utermohlen V, Hinton PS, Haas JD. Tissue iron deficiency without anemia impairs adaptation in endurance capacity after aerobic training in previously untrained women. Am J Clin Nutr 2004;79:437-443 (Pubitemid 41115588)
-
(2004)
American Journal of Clinical Nutrition
, vol.79
, Issue.3
, pp. 437-443
-
-
Brownlie IV, T.1
Utermohlen, V.2
Hinton, P.S.3
Haas, J.D.4
-
7
-
-
35248870765
-
Intravenous Iron Reduces NT-Pro-Brain Natriuretic Peptide in Anemic Patients with Chronic Heart Failure and Renal Insufficiency
-
DOI 10.1016/j.jacc.2007.07.029, PII S0735109707024588
-
Toblli JE, Lombraña A, Duarte P, Di Gennaro F. Intravenous iron reduces NT-pro-brain natriuretic peptide in anemic patients with chronic heart failure and renal insufficiency. J Am Coll Cardiol 2007;50:1657-1665 (Pubitemid 47562670)
-
(2007)
Journal of the American College of Cardiology
, vol.50
, Issue.17
, pp. 1657-1665
-
-
Toblli, J.E.1
Lombrana, A.2
Duarte, P.3
Di Gennaro, F.4
-
8
-
-
37849053243
-
Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency: FERRIC-HF: a randomized, controlled, observer-blinded trial
-
Okonko DO, Grzeslo A, Witkowski T, et al. Effect of intravenous iron sucrose on exercise tolerance in anemic and nonanemic patients with symptomatic chronic heart failure and iron deficiency: FERRIC-HF: a randomized, controlled, observer-blinded trial. J Am Coll Cardiol 2008;51:103-112
-
(2008)
J Am Coll Cardiol
, vol.51
, pp. 103-112
-
-
Okonko, D.O.1
Grzeslo, A.2
Witkowski, T.3
-
9
-
-
72449156527
-
Ferric carboxymaltose in patients with heart failure and iron deficiency
-
Anker SD, Comin Colet J, Filippatos G, et al. Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009;361:2436-2448
-
(2009)
N Engl J Med
, vol.361
, pp. 2436-2448
-
-
Anker, S.D.1
Comin Colet, J.2
Filippatos, G.3
|